2002—2013年上海市唾液腺恶性肿瘤流行情况分析

doi:10.19438/j.cjoms.2019.02.007

中国口腔颌面外科杂志 ›› 2019, Vol. 17 ›› Issue (2): 134-140.doi: 10.19438/j.cjoms.2019.02.007

2002—2013年上海市唾液腺恶性肿瘤流行情况分析

傅锦业^1,*, 吴春晓^2,*, 沈淑坤¹, 郑莹², 张陈平^1#, 张志愿^1#

1.上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科, 国家口腔疾病临床医学研究中心,上海市口腔医学重点实验室,上海市口腔医学研究所,上海 200011;
2.上海市疾病预防控制中心慢性非传染病与伤害防治所肿瘤防治科,上海 200336

收稿日期:2018-10-12 修回日期:2018-12-20 出版日期:2019-03-20 发布日期:2019-04-12
通讯作者: 张陈平,E-mail: zhang.chenping@hotmail.com;张志愿,E-mail: zhzhy639@163.com。^#共同通信作者
作者简介:傅锦业（1973-）,女,博士,主治医师,E-mail: fjy0712@hotmail.com;吴春晓（1981-）,男,硕士,主管医师,E-mail: wuchunxiao@scdc.sh.cn。^*并列第一作者
基金资助:
促进市级医院临床技能与临床创新能力三年行动计划项目（16CR2004A）

Salivary gland carcinoma in Shanghai from 2002 to 2013: an epidemiological study

FU Jin-ye¹, WU Chun-xiao², SHEN Shu-kun¹, ZHENG Ying², ZHANG Chen-ping¹, ZHANG Zhi-yuan¹

1.Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology. Shanghai 200011;
2.Department of Cancer Control & Prevention, Shanghai Municipal Center for Disease Control & Prevention. Shanghai 200336, China

Received:2018-10-12 Revised:2018-12-20 Online:2019-03-20 Published:2019-04-12

摘要/Abstract

摘要： 目的:分析上海市2002—2013年唾液腺恶性肿瘤的人群发病状况,阐明疾病在本地区的流行病学特点。方法:根据上海市疾病预防控制中心提供的唾液腺恶性肿瘤病例资料,通过数据重新核实,采用SPSS 17.0软件包统计唾液腺恶性肿瘤的发病率、性别比、年龄分布状况、解剖部位占比以及病理分布情况;采用年均变化百分比、 χ²检验和Fisher精确检验,比较年度之间的变化情况。结果:2002—2013年,上海市共诊断唾液腺恶性肿瘤新发病例2 308例,发病粗率为13.93/100万,标率为8.54/100万,性别比为1.08∶1;中位首诊年龄为58岁。12年间,发病率变化平稳。唾液腺恶性肿瘤中,1/3来自小唾液腺,其中1/3来自腭腺;大唾液腺的发病比为12∶3∶1。黏液表皮样癌、腺样囊性癌和非特异性腺癌是最常见的3大病理类型。结论:目前上海市唾液腺恶性肿瘤的发病率较低,但不同部位、不同病理类型的好发人群差异较大,提示发病危险因素存在差异,值得关注。

关键词: 唾液腺, 恶性肿瘤, 发病率, 流行病学, 人口学特征, 上海市

Abstract: PURPOSE: To analyze the incidence of salivary gland carcinoma in Shanghai from 2002 to 2013; And to clarify its epidemiological features. METHODS: The incidence data was retrieved from Shanghai Municipal Center for Disease Control & Prevention and re-checked before analysis. SPSS 17.0 software package was used to calculate the incidence rate, male/female ratio, age distribution, percentage of anatomic sites and demographic features of pathology. Comparisons of annual change were performed by annual percent change, Chi-square test and Fisher's exact test. RESULTS: A total of 2 308 cases were newly diagnosed of salivary gland carcinoma from 2002 to 2013 in Shanghai. The crude incidence rate was 13.93 per 1 000 000 and the age-adjusted incidence was 8.54 per 1 000 000. The male to female ratio was 1.08 with median age of 58 years old. The annual incidence was stable during the study period. Among the total cases, one third occurred in minor salivary gland with palate being the most common origin. Carcinoma from major salivary gland confirmed the 12∶3∶1 distribution. Mucoepidermoid, adenoid cystic carcinoma and adenocarcinoma NOS were the top three pathological types. CONCLUSIONS: The incidence of salivary gland carcinoma was relatively low in Shanghai. However, the demography of different pathologic types or anatomic sites varied widely, indicating different risk factors for these cancers which deserves more attention.

Key words: Salivary gland, Carcinoma, Incidence, Epidemiology, Demography, Shanghai

中图分类号:

R739.8

傅锦业, 吴春晓, 沈淑坤, 郑莹, 张陈平, 张志愿. 2002—2013年上海市唾液腺恶性肿瘤流行情况分析[J]. 中国口腔颌面外科杂志, 2019, 17(2): 134-140.

FU Jin-ye, WU Chun-xiao, SHEN Shu-kun, ZHENG Ying, ZHANG Chen-ping, ZHANG Zhi-yuan. Salivary gland carcinoma in Shanghai from 2002 to 2013: an epidemiological study[J]. China J Oral Maxillofac Surg, 2019, 17(2): 134-140.

参考文献

[1] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[2] Barnes L, Eveson JW, Reichart P, et al.World Health Organization classification of tumors: pathology and genetics of head and neck tumors [M]. Lyon: IARC Press, 2005.
[3] Pinkston JA, Cole P.Incidence rates of salivary gland tumors: results from a population-based study[J]. Otolaryngol Head Neck Surg, 1999, 120(6): 834-840.
[4] Bradley PJ, McGurk M. Incidence of salivary gland neoplasms in a defined UK population[J]. Br J Oral Maxillofac Surg, 2013, 51(5): 399-403.
[5] Bjorndal K, Krogdahl A, Therkildsen MH, et al.Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)[J]. Oral Oncol, 2011, 47(7): 677-682.
[6] Ostman J, Anneroth G, Gustafsson H, et al.Malignant salivary gland tumours in Sweden 1960-1989-an epidemiological study[J]. Oral Oncol, 1997, 33(3): 169-176.
[7] de Ridder M, Balm AJ, Smeele LE, et al. An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010)[J]. Cancer Epidemiol, 2015, 39(1): 14-20.
[8] 吴凡, 卢伟, 李德禄, 等. 上海市恶性肿瘤登记报告工作的调整与完善[J]. 中国肿瘤, 2002, 11(6): 316-318.
[9] 全国肿瘤防治研究办公室. 中国肿瘤登记工作手册 [M]. 北京: 中国协和医科大学出版社, 2004.
[10] Parkin DM, Chen VW, Ferlay J, et al.Comparability and quality control in cancer registration. IARC technical report No.19 [M]. Lyon: IARC Press, 1994.
[11] Shield KD, Ferlay J, Jemal A, et al.The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012[J]. CA Cancer J Clin, 2017, 67(1): 51-64.
[12] Boukheris H, Curtis RE, Land CE, et al.Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(11): 2899-2906.
[13] Swanson GM, Burns PB.Cancers of the salivary gland: workplace risks among women and men[J]. Ann Epidemiol, 1997, 7(6): 369-374.
[14] Horn-Ross PL, Ljung BM, Morrow M.Environmental factors and the risk of salivary gland cancer[J]. Epidemiology, 1997, 8(4): 414-419.
[15] Muscat JE, Wynder EL.A case/control study of risk factors for major salivary gland cancer[J]. Otolaryngol Head Neck Surg, 1998, 118(2): 195-198.
[16] Radoi L, Barul C, Menvielle G, et al.Risk factors for salivary gland cancers in France: Results from a case-control study, the ICARE study[J]. Oral Oncol, 2018, 80: 56-63.
[17] Horn-Ross PL, West DW, Brown SR.Recent trends in the incidence of salivary gland cancer[J]. Int J Epidemiol, 1991, 20(3): 628-633.
[18] Land CE, Saku T, Hayashi Y, et al.Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation related risk[J]. Radiat Res, 1996, 146(1): 28-36.
[19] Pan SY, de Groh M, Morrison H. A case-control study of risk factors for salivary gland cancer in Canada[J]. J Cancer Epidemiol, 2017, 2017: 4909214.
[20] Yoshida EJ, García J, Eisele DW, et al.Salivary gland malignancies in children[J]. Int J Pediatr Otorhinolaryngol, 2014, 78(2): 174-178.
[21] Gronhoj C, Hjalgrim L, Jakobsen KK, et al.Incidence of head and neck cancer in children: A Danish nationwide study from 1978 to 2014[J]. Pediatr Blood Cancer, 2018, 65(7): e27037.
[22] Levi S, Zini A, Fischman S, et al.Epidemiology of oral, salivary gland and pharyngeal cancer in children and adolescents between 1970 and 2011[J]. Oral Oncol, 2017, 67: 89-94.
[23] Kishi M, Nakamura M, Nishimine M, et al.Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas[J]. Oral Oncol, 2005 , 41(2): 161-169.
[24] Kupferman ME, de la Garza GO, Santillan AA, et al. Outcomes of pediatric patients with malignancies of the major salivary glands[J]. Ann Surg Oncol, 2010, 17(12): 3301-3307.
[25] Shapiro NL, Bhattacharyya N.Clinical characteristics and survival for major salivary gland malignancies in children[J]. Otolaryngol Head Neck Surg, 2006, 134(4): 631-634.
[26] Ribeiro Kde C, Kowalski LP, Saba LM, et al.Epithelial salivary glands neoplasms in children and adolescents: a forty-four-year experience[J]. Med Pediatr Oncol, 2002, 39(6): 594-600.
[27] Sultan I, Rodriguez-Galindo C, Al-Sharabati S, et al.Salivary gland carcinomas in children and adolescents: a population-based study, with comparison to adult cases[J]. Head Neck, 2011, 33(10): 1476-1481.
[28] 魏建国, 王强, 刘勇, 等. 2017版WHO唾液腺肿瘤分类解读[J]. 中华病理学杂志, 2018, 47(4): 306-310.
[29] Tian Z, Li L, Wang L, et al.Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population[J]. Int J Oral Maxillofac Surg, 2010, 39(3): 235-242.

2002—2013年上海市唾液腺恶性肿瘤流行情况分析

Salivary gland carcinoma in Shanghai from 2002 to 2013: an epidemiological study

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	曾丽婷, 吴嘉骏, 范晶娴, 王伟, 杨天页, 王繁麟, 徐兵, 葛奎. 拉出法与插入法经皮内镜下胃造瘘术在口腔颌面部恶性肿瘤患者中的应用效果比较[J]. 中国口腔颌面外科杂志, 2022, 20(4): 401-404.
[2]	韩林孜, 房义康, 禹雯怡, 王奇民, 童磊, 邱建忠, 袁荣涛. 口腔乳头状唾液腺瘤1例临床病理分析[J]. 中国口腔颌面外科杂志, 2022, 20(1): 98-100.
[3]	赵婷婷, 冯艳青, 何倩婷, 莫云龙, 董恩恩, 王安训. ATIP1和ATIP3a对口腔恶性肿瘤细胞增殖和凋亡的影响[J]. 中国口腔颌面外科杂志, 2021, 19(5): 417-423.
[4]	杜长江, 周侠, 马莲. 279例腭隐裂临床回顾分析[J]. 中国口腔颌面外科杂志, 2021, 19(5): 464-468.
[5]	高倩倩, 尚伟, 刘晓华. 颊部小唾液腺黏液囊肿误诊1例报告[J]. 中国口腔颌面外科杂志, 2021, 19(1): 91-93.
[6]	张卓宇, 撒国良, 魏泽全, 杨学文. 唾液腺:新型冠状病毒的“蓄水池”和“受累者”[J]. 中国口腔颌面外科杂志, 2020, 18(6): 486-489.
[7]	刘英, 李晨曦, 王冰, 龚忠诚. 热灌注化疗对口腔颌面部恶性肿瘤患者NO及T淋巴细胞的影响[J]. 中国口腔颌面外科杂志, 2020, 18(6): 521-525.
[8]	王少如, 高健刚, 徐竹青, 陈正岗, 郑建金, 邱建忠, 袁荣涛, 周建华. 精囊内镜用于诊断和治疗11例阻塞性唾液腺疾病的效果评价[J]. 中国口腔颌面外科杂志, 2020, 18(6): 544-547.
[9]	葛胜优, 周凯, 孔钰, 高策, 宋凯, 冯元勇, 尚伟. 数字化导航引导下¹²⁵I精确植入治疗9例颅底腺源性恶性肿瘤的效果评价[J]. 中国口腔颌面外科杂志, 2020, 18(3): 272-277.
[10]	沈逸超, 俞创奇, 王知俊, 张蔚蒨. 超声弹性成像在唾液腺非肿瘤疾病中的应用进展[J]. 中国口腔颌面外科杂志, 2020, 18(2): 177-181.
[11]	过筠, 何优雅, 陈一铭, 唐妍毅, 季彤. 21例儿童头颈部恶性肿瘤患者游离皮瓣修复临床分析[J]. 中国口腔颌面外科杂志, 2019, 17(6): 545-549.
[12]	汪洋, 夏亮, 胡宇华, 张春叶, 王丽珍, 李江, 田臻. 基于RNA-Seq分析挖掘唾液腺多形性腺瘤核心基因及通路[J]. 中国口腔颌面外科杂志, 2019, 17(5): 397-402.
[13]	黄嘉妮, 徐诸凤, 郁玺玺, 王悦平. PDCA护理模式在口腔恶性肿瘤患者行股前外侧皮瓣修复术围术期护理中的应用[J]. 中国口腔颌面外科杂志, 2019, 17(5): 440-443.
[14]	徐万林, 朱云, 卢浩, 刘丽敏, 沈淑坤, 刘胜文, 杨雯君. 15例下颌下腺复发性多形性腺瘤临床病理分析[J]. 中国口腔颌面外科杂志, 2019, 17(5): 465-468.
[15]	徐博雅, 杨子桧, 王珺, 雷德林, 杨新杰. CCL2和CCR2在唾液腺腺样囊性癌中的表达及意义[J]. 中国口腔颌面外科杂志, 2019, 17(4): 311-315.